Stockscreener 앱 받기
14.63
0.95%
-0.14
시간 외 거래:
14.63
전일 마감가:
$14.77
열려 있는:
$14.78
하루 거래량:
1.41M
Relative Volume:
0.89
시가총액:
$974.46M
수익:
$796.00M
순이익/손실:
$-136.49M
주가수익비율:
-7.00
EPS:
-2.09
순현금흐름:
$-64.24M
1주 성능:
-7.11%
1개월 성능:
-27.65%
6개월 성능:
-58.56%
1년 성능:
-66.49%
1일 변동 폭
$14.31
$14.98
1주일 범위
$14.31
$16.30
52주 변동 폭
$14.31
$47.60
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
14.63 | 1.05B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
What drives Tandem Diabetes Care Inc. stock priceRapidly growing investment returns - Autocar Professional
Down 27.0% in 4 Weeks, Here's Why You Should You Buy the Dip in Tandem Diabetes Care (TNDM) - Yahoo Finance
Wearable Injectors Market is expected to reach USD 24.99 billion - openPR.com
Digital Diabetes Management Market is projected to reach US$ - openPR.com
Diabetes Devices Market is projected to grow to US$ 64.8 billion - openPR.com
Tandem Diabetes Care Inc. Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional
What analysts say about Tandem Diabetes Care Inc. stockHigh-impact stock picks - jammulinksnews.com
Is Tandem Diabetes Care Inc. a good long term investmentUnprecedented profit potential - jammulinksnews.com
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Tandem Diabetes Care stock hits 52-week low at 14.86 USD - Investing.com
ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent
Tandem Diabetes Care’s SWOT analysis: stock faces headwinds amid market shifts - Investing.com
Lacklustre Performance Is Driving Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 27% Price Drop - simplywall.st
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity - FinancialContent
What makes Tandem Diabetes Care Inc. stock price move sharplyFree Exclusive Investment Tips - beatles.ru
Tandem Diabetes Care Inc (TNDM) Shares Decline 3.49% on July 11 - AInvest
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know - Yahoo.co
Lacklustre Performance Is Driving Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 28% Price Drop - 富途牛牛
Tandem Diabetes Care stock hits 52-week low at 15.34 USD By Investing.com - Investing.com South Africa
Tandem Diabetes Care stock hits 52-week low at 15.34 USD - Investing.com Nigeria
Tandem Diabetes Care Stock Downgraded to 'Sell' Amid Market ConcernsNews and Statistics - IndexBox
Why Tandem Diabetes (TNDM) Shares Are Sliding Today - TradingView
Tandem Diabetes Shares Drop Following Citi Downgrade Over Rising Competition - MSN
Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes - Investing.com Canada
Citigroup Downgrades Tandem Diabetes Care to Sell From Neutral, Cuts Price Target to $14 From $24 - MarketScreener
Aehr Test Systems Posts Downbeat Sales, Joins RxSight, Vertical Aerospace And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
(TNDM) Trading Advice - news.stocktradersdaily.com
Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 10.0% this week, taking five-year losses to 83% - Yahoo Finance
CMS eyes competitive bidding for CGMs, insulin pumps - BioWorld MedTech
Tandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
Why These Three Wearables Stocks Just Hit The Skids - Investor's Business Daily
Tandem Diabetes Care (NASDAQ:TNDM) Has Debt But No Earnings; Should You Worry? - simplywall.st
Multiple multianalyte sensors for diabetes on horizon - BioWorld MedTech
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors - MedTech Dive
TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 + - TradingView
Tandem Diabetes (TNDM) Expands Insulin Pump Features - GuruFocus
Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States | Daily Penny Alerts - FinancialContent
Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - MSN
How To Trade (TNDM) - news.stocktradersdaily.com
Digital Diabetes Management Market 2025Growth in Apps, - openPR.com
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities - FinancialContent
What Does Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Share Price Indicate? - Yahoo Finance
Tandem Diabetes Care’s SWOT analysis: stock faces growth hurdles amid market shifts - Investing.com UK
TNDM: Truist Securities Initiates Coverage with Hold Rating | TN - GuruFocus
TNDM: Truist Securities Initiates Coverage with Hold Rating | TNDM Stock News - GuruFocus
10 Best Stocks to Buy For Beginners Now - Insider Monkey
Truist bullish on diabetes companies citing potential market growth - Seeking Alpha
Truist initiates Tandem Diabetes Care stock with hold rating By Investing.com - Investing.com Canada
Tandem Diabetes (TNDM) Receives Hold Rating from Truist | TNDM S - GuruFocus
Truist Initiates Tandem Diabetes Care at Hold With $24 Price Target - MarketScreener
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
0.17%
자본화:
|
볼륨(24시간):